Anthim: Completed pivotal trial enrollment

Elusys completed enrollment of 280 adult volunteers in a double-blind, placebo-controlled, U.S. pivotal trial evaluating a single dose of 16 mg/kg IV ETI-204. The compound has Orphan Drug and Fast Tra...